Canadian Biotechnology Systems: The Stakeholders and the Institutional Infrastructure

View Sample PDF

Author(s): Johanne Queenton (University of Sherbrooke, Canada), Yvon Dufour (University of Sherbrooke, Canada)and Régis Milot (University of Sherbrooke, Canada)
Copyright: 2012
Pages: 12
Source title: Comparing High Technology Firms in Developed and Developing Countries: Cluster Growth Initiatives
Source Author(s)/Editor(s): Tomas Gabriel Bas (University Adolfo Ibañez, Chile)and Jingyuan Zhao (University of Québec at Montréal, Canada)
DOI: 10.4018/978-1-4666-1646-2.ch005

Keywords: Business Science Reference / Digital Divide & Developing Countries / Global Business / Government & Law

Purchase

View Canadian Biotechnology Systems: The Stakeholders and the Institutional Infrastructure on the publisher's website for pricing and purchasing information.

Abstract

In this chapter, the authors seek to estimate the importance of the clustering phenomenon in link with the biotechnological system as external factors that influence the growth of SBEs (specialised biotechnology enterprises). This is a first step in determining the geographical proximity of SBEs and researchers, and secondly, to identify the players involved in biotechnological systems of different clusters of agglomeration. Thus, the authors specify the number of SBEs by region, the number of researchers, and their links with industry. Therefore, in terms of biotechnological systems in place, the identification of the different stakeholders allow for revealing strengths and weaknesses of those regions for the sustaining of innovation in Canadian SBEs.

The IRMA Community

Research IRM

Canadian Biotechnology Systems: The Stakeholders and the Institutional Infrastructure

Purchase

Abstract

Related Content

IRMA Sponsors